![]() |
市场调查报告书
商品编码
1662792
2030 年手术缝合器市场预测:按产品类型、机制、应用、最终用户和地区进行的全球分析Surgical Staplers Market Forecasts to 2030 - Global Analysis By Product (Manual Surgical Staplers and Powered Surgical Staplers), Stapler Type, Mechanism, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球手术缝合器市值为 57.2 亿美元,预计到 2030 年将达到 87.6 亿美元,预测期内的复合年增长率为 9.2%。
手术缝合器是医疗设备。它提供了一种比传统缝合更快、更一致的替代方法,最大限度地减少组织创伤并缩短手术时间。这些仪器有助于精确密封内部和外部组织。缝合器有手动和电动两种类型,以及线性、圆形和内视镜类型,适用于各种手术,包括胃肠、胸腔外科和妇科手术。
根据美国国家医学图书馆 2023 年的一篇论文,印度每年进行的心血管手术数量估计约为 30 万例。
腹腔镜和机器人手术的激增
腹腔镜和机器人手术的激增大大增加了对先进手术器械的需求。这些微创手术需要精确、有效率、可靠的缝合装置来缝合切口、固定组织并进行吻合。机器人辅助手术尤其推动了专用缝合器的采用,因为它们具有更高的精确度和准确度。这一趋势加速了缝合器设计的创新,以确保与现代手术技术的兼容性,进一步推动了市场扩张。
併发症风险
手术缝合器併发症的风险,包括故障、组织密封不充分、洩漏和周围组织损伤,会严重影响患者的预后,包括感染疾病、出血和延长恢復时间。这些併发症是由于仪器使用不当、故障或钉仓放置不当造成的。这样的风险阻碍了医疗保健提供者采用手术缝合器,从而限制了其使用。随着病患安全问题日益严重以及监管机构实施更严格的指导方针,市场正面临采用和成长放缓的问题。
扩大医疗基础设施
随着医院和诊所升级到现代化、高效的设备,先进手术缝合器的需求正在增加。这些装置可以更快、更可靠地伤口缝合,减少手术时间并改善患者的治疗效果。医疗保健领域的投资正在成长,尤其是在新兴国家,获得高品质手术设备的管道也不断改善。此外,随着微创和机器人辅助手术的普及,对专用缝合器的需求正在增加,这进一步推动了市场成长并鼓励采用尖端手术技术。
昂贵的设备和消耗品
由于製造工艺先进、采用钛和聚乳酸等优质材料以及精密工程,手术缝合器价格昂贵。此外,需要墨盒和订书钉等专用零件也增加了成本。这些设备通常需要频繁更换,为医院和医疗保健提供者带来高昂的成本。因此,设备和消耗品的财务负担导致预算限制,这可能会减缓或限制某些地区和医疗保健环境中的采用,从而阻碍市场成长。
由于选择性手术延迟、住院人数减少以及供应链中断,COVID-19 疫情对手术缝合器市场产生了重大影响。许多非必要的手术,包括减肥手术和整容手术,都被推迟,从而减少了需求。不过,紧急和重症手术仍在继续,使得市场保持活跃。此外,对感染控制和微创手术的日益重视加速了先进缝合器的采用,从而推动了市场的成长。
可重复使用手术缝合器市场预计将在预测期内成长至最大
预计可重复使用手术缝合器部分将在预测期内占据最大的市场占有率。可重复使用的手术缝合器是医疗设备。它们采用不銹钢等耐用材料製成,是一种经济高效、环保的一次性订书机替代品。这些缝合器可以精确伤口缝合,同时减少医疗废弃物。
预计预测期内普通外科手术部分将以最高的复合年增长率成长。
预计预测期内普通外科手术部分将呈现最高的成长率。在一般外科手术中,手术缝合器广泛用于伤口缝合、吻合和组织切除。它比缝合线更精确,缩短了手术时间,并最大限度地减少了组织创伤。钛钉或可吸收钉能够提供牢固的闭合併促进癒合。
由于外科手术的增加、医疗保健投资的增加以及医疗保健基础设施的不断扩大,预计亚太地区将在预测期内占据最大的市场占有率。该地区人口老化以及癌症和肥胖症等慢性病的高发性导致手术对缝合器的需求增加。中国、印度和日本等国家是主要市场,受益于技术进步和微创手术的采用。总体而言,医疗保健服务的改善和技术创新正在推动市场扩张。
在预测期内,由于先进的医疗保健基础设施、较高的手术量以及微创手术的广泛采用,预计北美将呈现最高的复合年增长率。美国引领市场,这得益于慢性疾病患者数量的增加、减重相关手术以及缝合器材技术的进步。主要製造商的存在、严格的 FDA 法规以及对电动和吸收性订书机的不断增长的需求进一步推动了成长。总体而言,技术创新、人口老化和机器人辅助手术继续推动该地区的市场扩张。
According to Stratistics MRC, the Global Surgical Staplers Market is accounted for $5.72 billion in 2024 and is expected to reach $8.76 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Surgical staplers are medical devices used to close wounds, incisions, or surgical anastomoses by applying metal or absorbable staples. They provide a faster, more consistent alternative to traditional suturing, minimizing tissue trauma and reducing operative time. These devices help seal internal and external tissues with precision. Staplers come in manual and powered variants, with linear, circular, and endoscopic designs for various procedures, including gastrointestinal, thoracic, and gynaecological surgeries.
According to a 2023 article by the National Library of Medicine, the number of cardiac procedures performed in India are estimated to be around 300,000 per year.
Surge in laparoscopic and robotic surgeries
The surge in laparoscopic and robotic surgeries significantly increases the demand for advanced surgical tools. These minimally invasive procedures require precise, efficient, and reliable stapling devices to close incisions, secure tissue, and perform anastomoses. Robotic-assisted surgeries, in particular, offer enhanced accuracy and precision, boosting the adoption of specialized staplers. This trend accelerates innovation in stapler designs, ensuring their compatibility with modern surgical techniques, which further propels market expansion.
Risk of complications
The risk of complications with surgical staplers, such as misfiring, inadequate tissue sealing, leakage, or damage to surrounding tissues, can lead to severe patient outcomes, including infections, bleeding, or longer recovery times. These complications result from improper device use, malfunction, or poor staple placement. Such risks deter healthcare providers from adopting surgical staplers, limiting their usage. As patient safety concerns rise and regulatory bodies impose stricter guidelines, the market faces slower adoption and growth.
Expanding healthcare infrastructure
As hospitals and clinics upgrade to modern, efficient equipment, the demand for advanced surgical staplers rises. These devices offer faster, more reliable wound closure, reducing surgical time and improving patient outcomes. Growing investments in healthcare, especially in emerging economies, also lead to greater access to high-quality surgical tools. Additionally, as minimally invasive and robotic-assisted surgeries gain popularity, the need for specialized staplers increases, further propelling market growth and enhancing the adoption of cutting-edge surgical technologies.
Expensive devices and consumables
Surgical staplers are expensive due to advanced manufacturing processes, high-quality materials like titanium or polylactide, and precision engineering. Additionally, the need for specialized components such as cartridges and staples add to the cost. These devices often require frequent replacement, making them costly for hospitals and healthcare providers. Therefore, the financial burden of both the devices and consumables hampers market growth, as it may lead to budgetary constraints, delaying or limiting adoption in certain regions or healthcare environments.
The covid-19 pandemic significantly impacted the surgical staplers market due to postponed elective surgeries, reduced hospital admissions, and supply chain disruptions. Many non-essential procedures, including bariatric and cosmetic surgeries, were delayed, lowering demand. However, emergency and critical surgeries continued, sustaining market activity. Additionally, increased focus on infection control and minimally invasive procedures accelerated the adoption of advanced staplers, driving market growth.
The reusable surgical staplers segment is expected to be the largest during the forecast period
The reusable surgical staplers segment is expected to account for the largest market share during the forecast period. Reusable surgical staplers are medical devices designed for multiple uses after proper sterilization. Made from durable materials like stainless steel, they offer a cost-effective and environmentally friendly alternative to disposable staplers. These staplers provide precise wound closure while reducing medical waste.
The general surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the general surgery segment is predicted to witness the highest growth rate. In general surgery, surgical staplers are widely used for wound closure, anastomosis, and tissue resection. They enhance precision, reduce operative time, and minimize tissue trauma compared to sutures. They provide secure closures with titanium or absorbable staples, improving healing.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing surgical procedures, rising healthcare investments, and expanding medical infrastructure. The region's aging population and higher prevalence of chronic diseases, such as cancer and obesity, drive demand for staplers in surgeries. Countries like China, India, and Japan are key markets, benefiting from technological advancements and the adoption of minimally invasive procedures. Overall, improving healthcare access and innovation fuel market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by the advanced healthcare infrastructure, high surgical volumes, and strong adoption of minimally invasive procedures. The U.S. leads the market, driven by rising chronic disease cases, obesity-related surgeries, and technological advancements in stapling devices. The presence of major manufacturers, stringent FDA regulations, and increasing demand for powered and absorbable staplers further boost growth. Overall, innovation, an aging population, and robotic-assisted surgeries continue to drive market expansion in the region.
Key players in the market
Some of the key players in Surgical Staplers market include Medtronic, Johnson & Johnson (Ethicon), 3M Company, B. Braun Melsungen AG, Conmed Corporation, Intuitive Surgical, Inc., Smith & Nephew plc, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Meril Life Sciences Pvt. Ltd., OSSIO Inc., Frankenman International Limited, Welfare Medical Ltd., Reach Surgical, Inc., Grena Ltd., Miconvey Innovation, Panther Healthcare and Surgnova Healthcare Technologies.
In May 2024, Ethicon, a Johnson & Johnson MedTech company, launched the ECHELON LINEAR(TM) Cutter. It is the first linear cutter to market with combined innovative and proprietary technologies - 3D-Stapling Technology and Gripping Surface Technology (GST) - two advanced capabilities proven to enable greater staple line security, which can help surgeons reduce risks and support patient outcomes.
In February 2023, OSSIO Inc., announced the introduction of the new OSSIOfiber(R) Compression Staple, the next step towards becoming the gold standard in orthopedic fixation. OSSIO's fifth product family, OSSIOfiber(R) Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.